Open mobile menu
JP3 1408
Insights

News

Stay up to date with news about Secerna and intellectual property topics.

Antibodies

Update on the patentability of antibodies at the European Patent Office

European News 14/03/2024

In a series of articles relating to the patentability of antibodies, we have previously provided an outline of the requirements associated with patenting antibodies and related biologics at the European Patent Office (EPO). In particular, we focused on the different ways an antibody can be claimed at the EPO and also the information often required in a patent application to support the presence of an inventive step.

Read more
Antibodies
European, News 14/03/2024

Update on the patentability of antibodies at the European Patent Office

Secerna Website Images 2023 (41)
Events 10/03/2024

Jason Boakes will be in Atlanta for the INTA 2024 Annual Meeting

Secerna To Attend BIO International San Diego
Events 09/03/2024

Secerna to attend BIO International Convention in San Diego, USA

Secerna Website Images 2023 (40)
News 08/03/2024

Seen and Saved: Protecting Innovation in High-Visibility Clothing Technology

JP3 1192
European, Industry news, News 06/03/2024

Important Update: EPO Guidelines for Examination 2024 Now in Effect

EPO 2021
European, Industry news, News 05/03/2024

EPO Clarifies "Method of Treatment" Objections for MedTech Innovations

1 2 3 4 5 6